Posted:
6/5/2025, 2:42:30 AM
Location(s):
Massachusetts, United States ⋅ Cambridge, Massachusetts, United States
Experience Level(s):
Expert or higher ⋅ Senior
Field(s):
Business & Strategy
Company Overview:
Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is looking for a strategic leader to drive market access strategy for key BEAM assets, with a primary focus on BEAM-101. Reporting to the Vice-President of Market Access & Public Policy, the Senior Director, Market Access Strategy’s responsibilities include creating and developing tactics and market access deliverables for all payer types (Medicaid, Medicare, and Commercial), as well as IDN / health systems, to support the launch of BEAM products. This individual will create the market access strategy to support coverage across the access landscape, identifying customer & competitive insights, and evolving the value proposition and supporting deliverables accordingly to ensure optimal impact and utility.
Responsibilities:
This role will provide you the opportunity to lead key activities to progress your career, including but not limited to:
Qualifications:
Website: https://beamtx.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 501-1000
Year Founded: 2017
IPO Status: Public
Last Funding Type: Post-IPO Equity
Industries: Biotechnology ⋅ Genetics ⋅ Medical ⋅ Therapeutics